Show
Sort by
-
International eDelphi study to reach consensus on the methotrexate dosing regimen in patients with psoriasis
-
- Journal Article
- A1
- open access
Biologic therapies for severe asthma
-
- Journal Article
- A1
- open access
Long‐term efficacy and safety of brodalumab in moderate‐to‐severe plaque psoriasis : a post hoc pooled analysis of AMAGINE‐2 and ‐3
-
- Journal Article
- A1
- open access
Real-life effectiveness of mepolizumab in severe asthma : a systematic literature review
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
- Journal Article
- A1
- open access
Global Initiative for Asthma Strategy 2021 : executive summary and rationale for key changes
-
Anti–interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry